ReviewAdvances in experimental medicine and biology2026
The Era of Large-Scale Data in Biological Sciences.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We are living in the era of large-scale data in the biological sciences. The completion of the Human Genome Project (HGP) marked a pivotal moment, not only for its monumental achievement but also for introducing the concept of Big Science to the life sciences. This project catalysed a technological revolution, shifting biology from a primarily descriptive and hypothesis-driven discipline to a data-intensive, interdisciplinary field capable of systematic and quantitative exploration of biological systems at an unprecedented scale.This new paradigm is embodied by omics approaches, defined as experimental methods based on technologies that enable the systematic, qualitative, quantitative, and unbiased characterization of all molecular components of a given type within a biological system, or the interactions between them. From genomics and transcriptomics to proteomics and metabolomics, these technologies have moved us from studying individual molecules to capturing global views of biological processes. This has been fundamental for the emergence of Systems Biology, a unifying approach that seeks to understand complex biological systems by identifying their components and interactions and predicting systems behaviour through mathematical and computational models.In this chapter we provide an overview of the rise of the "-omes" and their corresponding omics approaches, their conceptual foundations, and the implications they carry for research in the life sciences, including controversies, challenges, and opportunities. We conclude by discussing how the convergence of omics and artificial intelligence is reshaping the epistemological foundations of biological research, bridging data accumulation and inference of molecular mechanisms.
Indexed as
Identifiers
42071137What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.